Human Reproduction, Vol. 18, No. 1, 90-95,
January 2003
© 2003 European Society of Human Reproduction and Embryology
Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen
The Center for Reproductive Medicine and Infertility, Joan and Sanford I. Weill Medical College of Cornell University, 505 East 70th Street, HT-340, New York, NY 10021, USA 1 To whom correspondence should be addressed. e-mail: kuo9001{at}med.cornell.edu
BACKGROUND: Breast cancer chemotherapy commonly causes premature ovarian failure and infertility. Because increased estrogen levels are thought to be potentially risky in breast cancer patients, natural cycle IVF (NCIVF) has been used to preserve fertility and treat infertility in these women. METHODS: Twelve women with breast cancer received 40–60 mg tamoxifen for 6.9 ± 0.6 days beginning on days 2–3 of their menstrual cycle (15 cycles), and had IVF (TamIVF) with either fresh embryo transfer (six cycles) or cryopreservation (nine cycles). They were compared to a retrospective control group (n = 5) who had natural cycle IVF (NCIVF, nine cycles). RESULTS: Cycle cancellation was significantly less frequent in TamIVF, compared with NCIVF (1/15 versus 4/9, P < 0.05). Compared with NCIVF, TamIVF patients had a greater number of mature oocytes (1.6 ± 0.3 versus 0.7 ± 0.2, P = 0.03) and embryos (1.6 ± 0.3 versus 0.6 ± 0.2, P = 0.02) per initiated cycle. TamIVF resulted in the generation of embryo(s) in every patient (12/12) while only three out of five patients had an embryo following NCIVF. Two out of six patients in TamIVF, and 2/5 in NCIVF conceived. One patient in the TamIVF group delivered a set of twins. After a mean follow up of 15 ± 3.6 months (range 3–54), none of the patients had a recurrence of cancer. CONCLUSIONS: Tamoxifen stimulation appears to result in a higher number of embryos and may provide a safe method of IVF and fertility preservation in breast cancer patients.
Key words: breast cancer/fertility preservation/IVF/ovarian stimulation/tamoxifen
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rosendahl, C. Y. Andersen, E. Ernst, L. G. Westergaard, P. E. Rasmussen, A. Loft, and A. N. Andersen Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study Hum. Reprod., November 1, 2008; 23(11): 2475 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Partridge Fertility Preservation: A Vital Survivorship Issue for Young Women With Breast Cancer J. Clin. Oncol., June 1, 2008; 26(16): 2612 - 2613. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Partridge Fertility Preservation Considerations in Young Women with Breast Cancer ASCO Educational Book, January 1, 2008; 2008(1): 36 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay Fertility Preservation Options for Young Women with Cancer ASCO Educational Book, January 1, 2008; 2008(1): 43 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Azim, M. Costantini-Ferrando, K. Lostritto, and K. Oktay Relative Potencies of Anastrozole and Letrozole to Suppress Estradiol in Breast Cancer Patients Undergoing Ovarian Stimulation before in Vitro Fertilization J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2197 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, A. Cil, and H. Bang Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3885 - 3890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sonmezer and K. Oktay Fertility preservation in young women undergoing breast cancer therapy. Oncologist, May 1, 2006; 11(5): 422 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Knobf The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. Oncologist, February 1, 2006; 11(2): 96 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Goodwin, K. H. Oktay, and R. A. Lobo Options for preservation of fertility in women. N. Engl. J. Med., September 29, 2005; 353(13): 1418 - 1420. [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation J. Clin. Oncol., July 1, 2005; 23(19): 4347 - 4353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Partridge and E. P. Winer Fertility After Breast Cancer: Questions Abound J. Clin. Oncol., July 1, 2005; 23(19): 4259 - 4261. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oehninger Strategies for Fertility Preservation in Female and Male Cancer Survivors Reproductive Sciences, May 1, 2005; 12(4): 222 - 231. [Abstract] [PDF]
|
|
|
|
 |
|
 J. E. Roberts and K. Oktay Fertility Preservation: A Comprehensive Approach to the Young Woman With Cancer J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 57 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Duffy, S. M. Allen, and M. A. Clark Discussions Regarding Reproductive Health for Young Women With Breast Cancer Undergoing Chemotherapy J. Clin. Oncol., February 1, 2005; 23(4): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sonmezer and K. Oktay Fertility preservation in female patients Hum. Reprod. Update, May 1, 2004; 10(3): 251 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay and M. Sonmezer Ovarian tissue banking for cancer patients: Fertility preservation, not just ovarian cryopreservation Hum. Reprod., March 1, 2004; 19(3): 477 - 480. [Abstract] [Full Text] [PDF]
|
|